» Articles » PMID: 35955793

Diclofenac-Induced Cytotoxicity in Direct and Indirect Co-Culture of HepG2 Cells with Differentiated THP-1 Cells

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2022 Aug 12
PMID 35955793
Authors
Affiliations
Soon will be listed here.
Abstract

Non-steroidal anti-inflammatory drugs (NSAIDs) such as diclofenac (DIC) frequently induce drug-induced liver injury (DILI). It is unclear whether macrophages such as M1 and M2 participate in NSAID-associated DILI; elucidating this relationship could lead to a better understanding of the detailed mechanism of DILI. We co-cultured human hepatoma HepG2 cells with M1 or M2 derived from human monocytic leukemia THP-1 cells to examine the roles of M1 and M2 in DIC-induced cytotoxicity. DIC was added to the direct or indirect co-cultures of HepG2 cells with M1 or M2 (HepG2/M1 or HepG2/M2, respectively) at cell ratios of (1:0, 1:0.1, 1:0.4, and 1:1). In both direct and indirect HepG2/M2 co-cultures (1:0.4), there was lower lactate dehydrogenase release compared with HepG2/M1 co-cultures. Other NSAIDs as well as DIC showed similar protective effects of DIC-induced cytotoxicity. There were only slight differences in mRNA levels of apoptosis- and endoplasmic reticulum stress-associated factors between M1 and M2 after DIC treatment, suggesting that other factors determined the protective effects of M2 on DIC-induced cytotoxicity. Levels of high mobility group box 1 (HMGB1) in the medium and the mRNA expression levels of HMGB1 receptors were different between M1 and M2 after DIC treatment. Increased HMGB1 concentrations and expression of toll-like receptor 2 mRNA in M1 were observed compared with M2 after DIC treatment. In conclusion, these results suggested that the HMGB1/TLR2 signaling axis can be suppressed in M2 but not M1, leading to the different roles of M1 and M2 in NSAID-induced cytotoxicity.

Citing Articles

Novel insights into vancomycin-loaded calcium sulfate and negative pressure wound therapy in preventing infections in open fractures.

Jia B, Xue R, Li J, Guo J, Liu J J Orthop Surg Res. 2024; 19(1):517.

PMID: 39198853 PMC: 11360527. DOI: 10.1186/s13018-024-04931-5.


Exploiting the predictive power of educated spheroids to detect immune-mediated idiosyncratic drug-induced liver injury: the case of troglitazone.

Roux S, Cherradi S, Duong H Front Pharmacol. 2024; 15:1378371.

PMID: 38659594 PMC: 11039894. DOI: 10.3389/fphar.2024.1378371.


Downregulation of HMGB1 carried by macrophage-derived extracellular vesicles delays atherosclerotic plaque formation through Caspase-11-dependent macrophage pyroptosis.

Liang W, Wei R, Zhu X, Li J, Lin A, Chen J Mol Med. 2024; 30(1):38.

PMID: 38493291 PMC: 10943908. DOI: 10.1186/s10020-023-00753-z.

References
1.
Sunman J, Hawke R, LeCluyse E, Kashuba A . Kupffer cell-mediated IL-2 suppression of CYP3A activity in human hepatocytes. Drug Metab Dispos. 2004; 32(3):359-63. DOI: 10.1124/dmd.32.3.359. View

2.
Gordon S . Alternative activation of macrophages. Nat Rev Immunol. 2003; 3(1):23-35. DOI: 10.1038/nri978. View

3.
Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, Locati M . The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 2004; 25(12):677-86. DOI: 10.1016/j.it.2004.09.015. View

4.
Akasaka J, Naruse K, Sado T, Uchiyama T, Makino M, Yamauchi A . Involvement of Receptor for Advanced Glycation Endproducts in Hypertensive Disorders of Pregnancy. Int J Mol Sci. 2019; 20(21). PMC: 6862609. DOI: 10.3390/ijms20215462. View

5.
Zhang C, Gdynia G, Ehemann V, Roth W . The HMGB1 protein sensitizes colon carcinoma cells to cell death triggered by pro-apoptotic agents. Int J Oncol. 2014; 46(2):667-76. DOI: 10.3892/ijo.2014.2785. View